Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease

Although guidelines recommend amikacin (AMK) inhalation therapy for difficult-to-treat nontuberculous mycobacterial lung disease (NTM-LD), data are limited regarding the safety and clinical efficacy of this salvage therapy. We retrospectively evaluated the treatment outcomes of 77 patients with refr...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Antimicrob Agents Chemother
Main Authors: Jhun, Byung Woo, Yang, Bumhee, Moon, Seong Mi, Lee, Hyun, Park, Hye Yun, Jeon, Kyeongman, Kwon, O Jung, Ahn, Jungmin, Moon, Il Joon, Shin, Sung Jae, Daley, Charles L., Koh, Won-Jung
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology 2018
Fag:
Clinical Therapeutics
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6021683/
https://ncbi.nlm.nih.gov/pubmed/29661870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00011-18
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker